Form D · Other Health Care

BionX Medical Technologies, Inc.

Cambridge, MA · CIK 0001413686

Offering snapshot reported Dec 23, 2015 · SEC filing

Reported sold
$17.1M
Indefinite offering
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 11, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$8.53M$17.1MDec 23, 2014: $6,000,000.00Dec 23, 2014Dec 23, 2015: $17,057,767.00Dec 23, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,000,000 → $17,057,767
  • Reported investors18 → 21

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 23, 2015Amendment$17,057,767$11,057,767vs Dec 23, 201421SEC filing
Dec 23, 2014Initial$6,000,000No comparison18SEC filing
Sep 13, 2012Initial$13,263,639No comparison15SEC filing
Jul 2, 2012Initial$3,132,414No comparison9SEC filing
Jan 19, 2011Initial$15,048,924No comparison11SEC filing
Aug 28, 2009Initial$20,000,000No comparison11SEC filing
Sep 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-230776
The figures reflected in items 13 and 14 include four non-U.S. purchaser investing a total of $11,431,748.

Source: Form D, filed Dec 23, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Charles Carignan Director, Executive
Richard J. Casler, Jr. Executive
Kevin Connors Director
William F. Doyle Director
Michael Ellenbogen Director
Paul Flanagan Director
Richard M. Greenwald Director, Executive
Hugh Herr Director
Timothy J. Langloss Director, Executive
Timothy A. Mc Carthy Director, Executive
Geoff Pardo Executive
David Reissfelder Executive
William Sahlman Director
John Simon Director
Ian Vawter Executive
Ruibo Xu Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
222 Third Street #3130
Cambridge, MA, 02142